Toward the rational design of molecular rotors ion sensors based on a,c-cyclic peptide dimers
623
d): 174.3 (CO), 157.8 (CO), 133.1 (C), 132.6 (C), 132.4 (C),
130.8 (CH), 129.3 (CH), 129.0 (CH), 128.2 (CH), 127.4
(CH), 126.6 (CH), 125.5 (CH), 125.4 (CH), 119.3 (C), 92.0
(C), 82.6 (C), 80.8 (C), 62.7 (CH2), 54.2 (CH), 28.7 (CH3),
24.2 (CH2); FTIR (293K, CHCl3): 3433, 2983, 2929, 2854,
1722, 1515 cm-1; MS (ES1) [m/z (%)]: 436 ([M ? Na]?,
36), 414 ([MH]?, 16), 314 ([MH-Boc]?, 100); HRMS
[MH]? calculated for C26H24NO4 414.1700, found
414.1703.
dissolved in CH2Cl2 (20 mL) and the solution washed with
HCl (5%), dried over Na2SO4, filtered and concentrated. The
resulting residue was dissolved in a TFA/CH2Cl2 mixture
(1:1, 6.9 mL) and stirred at room temperature for 15 min.
After removal of the solvents, the residue was dried under
high vacuum and used without further purification. The linear
peptide was dissolved in CH2Cl2 (688 mL) and treated with
HATU (288 mg, 0.76 mmol), followed by dropwise addition
of DIEA (720 lL, 4.19 mmol). The resulting mixture was
stirred for 10 h at room temperature to complete the reaction
and then the solvent was removed under reduced pressure.
The resulting residue was purified by HPLC, affording
500 mg of a,c-CP5 as a white solid [63%, Rt = 13 min
(Phenomenex Maxsil-10 silica semipreparative column,
7–12% MeOH in CH2Cl2, 25 min)]. 1H NMR (CDCl3,
500.14 MHz, d): 8.40–7.68 (m, 12H, 3NH, Pyr), 7.37-7.27
(m, 8H, Bn), 7.25–7.20 (m, 2H, Bn), 5.32-4.92 (m, 7H, CH2-
Bn, a-Prg, Glu and Lys), 4.86–4.67 (m, 3H, Hc Acp),
3.42–3.22 (m, 2H, CH2-Pyr), 3.17–3.08 (m, 2H, CH2-Lys),
3.05–2.96 (m, 9H, CH3), 2.96–2.87 (m, 3H, Ha Acp),
2.46–2.21 (m, 6H, Acp), 2.22–1.98 (m, 4H), 1.97–1.11 (m,
30H);13C NMR (CDCl3, 125.76 MHz, d): 175.4(CO), 175.3
(CO), 173.1 (CO), 172.5 (CO), 156.5 (CO), 136.5 (C), 136.2
(C), 135.9 (C), 135.6 (C), 131.3 (CH), 130.8 (CH), 129.7
(CH), 128.5 (CH), 128.4 (CH), 128.2 (CH), 128.0 (CH),
128.0 (CH), 127.4 (CH), 127.2 (CH), 126.6 (CH), 125.8
(CH), 124.7 (CH), 123.3 (CH), 123.1 (CH), 66.5 (CH2), 54.8
(CH), 50.2 (CH), 48.3 (CH), 47.8 (CH), 42.5 (CH2), 42.3
(CH), 40.6 (CH2), 35.9 (CH2), 33.0 (CH2), 30.2 (CH3), 29.9
(CH3), 29.8 (CH3), 28.3 (CH2), 27.6 (CH2), 27.1 (CH2), 26.9
(CH2), 22.5 (CH2); FTIR (293K, CHCl3): 3435, 3302, 2943,
2873, 2359, 1718, 1620, 1525 cm-1; MS (ES1) [m/z (%)]:
1156 ([MH]?, 100), 578 ([MH]2?, 23); HRMS [MH]? cal-
culated for C68H82N7O10 1156.6118, found 1156.6111.
(L)-2-(tert-butoxycarbonylamino)-5-(pyren-1-yl)penta-
noic acid (L-Boc-Pap-OH) A solution of (L)-2-(tert-
butoxycarbonylamino)-5-(pyren-1-yl)pent-4-ynoic
acid
(110 mg, 0.27 mmol) in ethanol (9 mL) and acetic acid
(45 lL) was degassed for 15 min and then treated with Pd/
C (10%, 56 mg) and stirred overnight at room temperature
under balloon pressure of hydrogen. The resulting mixture
was filtered through a Celite pad, the residue was washed
with ethanol, and the filtrates were concentrated under
reduced pressure. The reaction crude was purified by flash
chromatography (2%EtOH/CH2Cl2 with 0.5% AcOH)
affording 98 mg of L-Boc-Pap-OH as a yellow foam
[88%, Rf = 0.25 (5% MeOH in CH2Cl2)]. 1H NMR
(CD3OD, 500.14 MHz, d): 8.24 (d, J = 9.2 Hz, 1H), 8.10
(d, J = 7.6 Hz, 2H), 8.07–8.02 (m, 2H), 7.99–7.90 (m,
3H), 7.82 (d, J = 7.6 Hz, 1H), 4.27–4.07 (m, 1H),
3.43–3.15 (m, 2H), 2.08-1.66 (m, 4H), 1.39 (s, 9H); 13C
NMR (CD3OD, 125.76 MHz, d): 158.2 (CO), 137.6 (CO),
132.8 (CO), 132.4 (CH), 132.3 (CH), 131.2 (CO), 129.8
(CH), 128.5 (CH), 128.4 (CH), 128.3 (CH), 127.6 (CH),
126.9 (CH), 126.2 (C), 126.1 (C), 125.9 (CH), 125.7 (CH),
124.4 (CH), 80.5 (C), 69.1 (CH2), 40.1 (C), 33.8 (CH2),
32.8 (CH2), 31.6 (CH2), 30.1 (CH2), 29.3 (CH2), 28.7
(CH), 24.9 (CH2), 24.0 (CH2); FTIR (293 K, CHCl3):
3422, 2975, 2928, 2863, 2367, 1722, 1515 cm-1; MS
(ES1) [m/z (%)]: 440 ([M ? Na]?, 100), 418 ([MH]?, 11),
318 ([MH–Boc]?, 58); HRMS [MH]? calculated for
C26H28NO4 418.2013 found 418.2013.
c-[L-Pap-D-MeN-c-Acp-L-Glu-D-MeN-c-Acp-L-Lys-D-Me
N-c-Acp-] (a,c-CP6) To a mixture of c-[L-Pap-D-MeN-c-
Acp-L-Glu(OBn)-D-MeN-c-Acp-L-Lys(Z)-D-MeN-c-Acp-]
(a,c-CP5) (429 mg, 0.37 mmol), pentamethylbenzene
(429 mg, 2.89 mmol) and anisole (430 lL, 4 mmol) in
TFA (43 mL) was treated with HBr/AcOH (33%, 8.6 mL,
45 mmol). After stirring 4 h at room temperature, the
solvent was removed under reduced pressure, and the crude
was purified by HPLC, affording 215 mg of a,c-CP6 as a
white solid [50%, Rt = 29 min (Sugelabor Inertsil C18
column, 60–85% MeOH in H2O)]. 1H NMR (DMSO:
CDCl3 (20:80), 500.14 MHz, d): 8.31–7.63 (m, 12H), 4.93-
4.65 (m, 3H), 2.96–2.82 (m, 4H), 2.78–2.61 (m, 3H),
2.55–2.46 (m, 6H), 2.22–2.12 (m, 1H), 1.99–0.97 (m,
18H); 13C NMR (DMSO: CDCl3 (30:70), 125.76 MHz, d):
173.1 (CO), 172.4 (CO), 170.3 (CO), 170.0 (CO), 134.8
(C), 129.3 (C), 128.8 (C), 127.7 (C), 126.5 (CH), 125.7
(CH), 125.4 (CH), 124.8 (CH), 124.2 (CH), 123.1 (CH),
Peptide synthesis
Linear peptides Boc-[L-Pap-D-MeN-c-Acp-L-Glu(OBn)-
D-MeN-c-Acp-L-Lys(Z)-D-MeN-c-Acp-]OFm was prepared
following the synthetic strategy previously described (see
´
also Supplementary materials, Amorın et al. 2005 and Brea
et al. 2005).
c-[L-Pap-D-MeN-c-Acp-L-Glu(OBn)-D-MeN-c-Acp-L-Lys
(Z)-D-MeN-c-Acp-] (a,c-CP5) A solution of Boc-[L-Pap-
D-MeN-c-Acp-L-Glu(OBn)-D-MeN-c-Acp-L-Lys(Z)-D-MeN-
c-Acp-]-OFm (988 mg, 0.68 mmol) in a piperidine/CH2Cl2
solution (1:4, 6.9 mL) was stirred at room temperature for
20 min. After removal of the solvent, the residue was
123